1/29
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced |
|---|
No study sessions yet.
Beta-oxidation of monosaturated fatty acid
Cis oleoyl-CoA (18:1 delta 9), goes through 3 beta-oxidation cycles creating a 12-Carbon cis-delta3,4-fatty acyl-CoA
Cis 3,4-CoA double bond cannot be processed by the first two beta-oxidation enzymes without rearrangement, must get a cis 3,4 double bond to trans 2,3 double bond
Enoyl-CoA isomerase converts the stalled cis-delta3-enoyl-CoA into the trans-delta2-enyol-CoA
Can then enter standard beta-oxidation by enoyl-CoA hydratase
It skips the first step as the double bond is already present in the substrate, FADH2 isn't produced at this cycle, leads to fewer ATP equivalents
Pre-existing unsaturation bypasses the initial dehydrogenation and reduces the total ATP yield per carbon
Mechanism of enoyl-CoA isomerase repositions double bonds to sustain beta-oxidation of monounsaturated fats
Issues with MUFAs
Beta-oxidation enzymes act only on trans-delta2-enoyl-CoA intermediates
Oxidation of a double bond located at an odd carbon creates a delta3-enoyl-CoA intermediates
Solution
Enoyl-CoA isomerase repositions the double bond to form the required trans-delta2-enoyl-CoA, allows beta-oxidation to proceed
Catalyzes an intramolecular redox-neutral isomerization
Mechanism
Proton abstraction and re-addition causes double bond migration from C3-C4 to C2-C3 configuring the bond to trans
The active site uses a conserved glutamate to abstract the alpha proton (C2) and re-protonate at C4 to shift the pi bond
No change in oxidation state of substrate, just positional isomerization
Always yield trans-delta2-product with correct geometry for the next beta-oxidation step
Enzymatic Strategies in polyunsaturated fatty acid beta-oxidation
Start
Undergoes regular beta-oxidation until it reaches the double bond
Will use enoyl-CoA isomerase to shift a cis-delta3 double bond to the trans-delta2 form for continued beta-oxidation
Problem
After 4th round of oxidation and isomerization, it generates a 2,4-dienoyl-CoA which has 2 conjugated double bonds
Standard beta-oxidation enzymes only act on substrates with a single trans-delta2 doble bond
Solution
2,4-dienoyl-CoA reductase reduces the remaining conjugated dienoyl-CoA intermediates to trans-delta3-enoyl-CoA which is converted to trans-delta2enoyl-CoA by enoyl-CoA isomerase and processed by the standard beta-oxidation enzymes
2-4-dienoyl-CoA Reductase
Problem
Beta-oxidation of PUFAs produces 2,4-dienoyl-CoA intermediates (conjugated 2,4 double bonds)
Cannot be processed by standard beta-oxidation enzymes
Solution
Enzyme reduces the conjugated system to a single trans-delta3-enoyl-CoA
Isomerized to beta-oxidation compatible trans-delta2-enoyl-CoA by enoyl-CoA isomerase
Mechanism
DECR catalyzes conjugated diene to monoene reduction (2 double bond to 1)
NADPH transfers a hydride to C5, causes conjugated diene to be at C1 and C3 (oxygen takes electrons from C=O)
C2 is protonated to converts the 1-2 double bond into a 1-2 single bond
Only remaining doble bond is trans 3
Tyr and Asn active site residues stabilize tetrahedral intermediate to facilitate proton transfer
Enoyl-CoA isomerase
Cis delta 3 to trans delta 2
Standard hydratase needs trans delta 2
Glutamate abstracts alpha proton and reprotonates C4
Turns cis double bond into trans
2,4-dienoyl-CoA reductase
For conjugated 2,4-dienoyl-CoA to trans-delta3-enoyl-CoA
Standard enzymes reject conjugated systems
NADPH donates hydride to C5 and a proton to C2
Tyr and ASN stabilize the tetrahedral intermediate
Creates a trans double bond at C3
Final cycle of beta-oxidation, propionyl-CoA to TCA cycle
5C FA turns into Acetyl-CoA and propionyl-CoA
Propionyl-CoA uses propionyl-CoA carboxylase to add a carboxyl group on the middle carbon can produces D-methylmalonyl-CoA
Uses HCO3, ATP as substrates, biotin cofactor, ADP and Pi as product
Methylmalonyl-CoA epimerase converts D-methylmalonyl-CoA to L-methylmalonyl-CoA
CoA is moved from Carboxyl on the send to the newly added one on the middle carbon
Methylmalonyl-CoA mutase uses B12 to isomerize it into succinyl-COA
L-MM-CoA and succinyl-Coa are epimers (stereoisomers that differ at 1 chiral centre)
Carboxyl with CoA switches with a hydrogen on the other carbon end
Regulation of fatty acid breakdown
Key points
Entry into mitochondria - Carnitine Palmitoyltransferase 1 (CPT-1)
Rate limiting step of beta-oxidation
Inhibited by malonyl-COA linking fatty acid synthesis to degradation
Hormonal regulation
Glucagon and epinephrine stimulate beta-oxidation by increasing lipolysis and activating CPT-1 indirectly by reducing malonyl-CoA. MORE ENERGY
Insulin suppresses fatty acid breakdown, promotes malonyl CoA, and inhibit lipolysis, Don't need energy
Energy charge control
Buildup high NADH/NAD+ and acetyl-CoA slow beta-oxidation by mass-action (Q) and thermodynamic feedbac
Acetyl-CoA serves many purposes
Energy production
Feeds TCA for ATP generation
Biosynthesis
Building block for fatty acids, cholesterol, ketone bodies, isoprene's and some amino acids
Regulation
Donates acetyl groups for protein acetylation, influencing enzyme activity and gene expression
Integration of metabolism
Central node linking catabolic and anabolic pathways
Helps cell balance energy supply and biosynthetic demands
Condensation of acetyl-group enolates produces the branched intermediates beta-hydroxy-beta methylglutaryl-CoA (HMG-CoA)
Mitochondrial matrix, HMG-COA is cleaved to ketone bodies for export as fuel
In cytosol, converted into a 5 carbon isoprene unit, building block for terpenes, cholesterol and other complex lipids
Multiple copies of 5 carbon isoprene unit can be joined to form complex carbon skeletons in terpenes and steroids
HMG-CoA synthesis
2 acetyl-CoA join together, thiolase displaced CoA from one acetyl-CoA to form acetoacetyl-CoA
Reversible direction, depends on acetyl-CoA Concentration
High concentration = condensation is favoured over splitting, drives synthesis of downstream products
HMG-CoA synthase joins another acetyl-S-CoA to HMG-S-Coa + HS-CoA (+H2O)
Combines a third CoA tag, analogous to citrate synthase
Incoming acetyl-Coa forms an enolate to attack the carbonyl of acetoacetyl-CoA
Reaction is endergonic but driven forward by high acetyl-CoA levels and exergonic cleavage of acetyl-CoA thioester
Reaction is the same between mitochondrial HMG-CoA synthase for ketones and cytosolic HMG-COA synthase for isoprenoids
Ketogenesis, in the mitochondrial matrix
HMG-lyase in mito matrix cleaves CoA-linked acetyl group on HMG to generate acetoacetate for export from mitochondrial
HMG-S-COA > acetoacetate + acetyl-CoA
Acetoacetate unstable beta-keto carboxylate spontaneously decarboxylate to acetone (unusable fuel)
Uses acetoacetate decarboxylate to speed up reaction for ketone regulation
Reduction of beta keto group in acetoacetate by beta-hydroxybutyrate dehydrogenase to produce D-beta-hydroxybutyrate (BHB)
Ruses NADH and H+ as substrate
In humans most circulating ketone bodies are BHB, doesn't have a reactive ketone body
Ketolysis
Keton body catabolism in peripheral tissue is to generate energy
Requires bypass reaction as HMG-CoA synthase is absent in peripheral tissue
Converts BGB to acetyl-CoA for energy
Ketolysis Steps
BHB is oxidized to acetoacetate using BHB dehydrogenase and generates NADH
In all mitochondrial matrix of all tissue but the liver
ACA is activated by a CoA transfer from succinyl-CoA to from acetoacetyl-CoA which enters the TCA cycle as acetyl-CoA for ATP production
Succinyl-CoA:acetoacetate CoA-transferase or thiophorase
Transfers CoA from succinyl-CoA to acetoacetate forming acetoacetyl-CoA
Liver lacks this enzyme and cannot use keton bodies as fuel
Acetoacetyl-CoA is cleaved by thiolase into 2 molecules of acetyl-CoA to enter TCA cycle for oxidation and ATP production
Why acetyl-CoA cannot be turned into glucose and why it uses acetyl-CoA to make ketone bodies instead
Some sources of carbon can become glucose and are glucogenic
Intermediates of glycolysis, lactate and TCA 4 carbon intermediates can be used to make glucose
Enter gluconeogenesis
Acetyl-CoA cannot become glucose
Pyruvate dehydrogenase irreversibly converts pyruvate to acetyl-COA
There is no enzyme that converts acetyl-CoA back into pyruvate
Carbon in acetyl-CoA is ketogenic
Acetyl-CoA cannot contribute to net glucose production
It is ketogenic carbon, form ketone bodies instead of glucose
It doesn't increase pool of oxaloacetate, for every one acetyl-CoA it generates one oxaloacetate
Ketogenic exportable fuel
Ketogenic carbon is stored as fatty acids in adipocytes
Fasting or glucagon stim released fatty acids are oxidized by the liver to acetyl-CoA
When Acetyl-CoA exceeds the liver's oxidative capacity, it diverts to ketogenesis forming acetoacetate, beta-hydroxybutyrate and acetone
When ketone bodies are formed
Ketone bodies are exported from the liver and use as an immediate, water-soluble energy source by heart, skeletal muscle, renal cortex and brain when need
Tissue converts acetoacetate and beta-hydroxybutyrate back to acetyl-CoA
Acetyl-CoA enters the TCA to generate ATP
Acetone is exhale and not metabolized
Ketone vs Fatty acids
Ketone body are not a storage form of energy, it is a transportable intermediate
Ketone body is produced by the liver during carbohydrate scarcity to distribute acetyl-CoA to tissue that need it
Acetyl-CoA is membrane impermeable and can't leave cells
Liver synthesize but can't use ketone
Lack enzyme to convert back to acetyl-CoA
Peripheral tissue has thiophorase
4-carbon pool availability decides acetyl-CoA fate in liver
In a glucagon response, liver gets ATP from FA catabolism (glucose is for export not catabolism)
4C dicarboxylate pool, OAA, is used for gluconeogenesis. During fasting liver's priority is to export glucose.
OAA > PEP > gluconeogenesis > glucose
If glucagon signal is prolonged, OAA is depleted turning into glucose
Lower OAA = less acetyl-CoA enter TCA cycle
Acetyl-COA accumulates and is diverted to ketogenesis
Less acetyl-CoA entering TCA = less ATP supply so then liver uses amino acids for energy
During fasting OAA is used to make glucose, leaving too little to run the TCA cycle, forces accumulate acetyl-CoA to be converted into ketone bodies
HMG-CoA: Branch point for ketones and isoprenoids
Assembly for acetyl-group enolates produces a branched intermediates HMG-CoA
This is where it differs
Mitochondrial matrix
HMG-CoA serves as the precursor for ketone body synthesis
HMg-CoA > acetoacetate > acetone and reduces to BHB (D-betahydroxybutyrate) (ketogenesis)
BHB > acetoacetate > acetoacetyl-CoA (uses thiophorase)
Acetoacetate is able to transport to and from the blood
Occurs in all tissue but the liver
In the cytosol
HMG-CoA is diverted to produce 5-carbon isoprene units
Building blocks for cholesterol and other isoprenoids
Occurs in all tissues
Isoprenoid synthesis
Stage 1: Formation of mevalonate
Mirror ketogenesis but occur in the cytosol using distinct isozymes
Formation of acetoacetyl-CoA
2 acetyl-CoA condense to form acetoacetyl-CoA
thiolase
Reversible and doesn't commit cell to isoprenoid synthesis
Formation of HMG-CoA
Acetoacetyl-CoA condenses with a third acetoacetyl-CoA condenses with a third acetyl-CoA to generate HMG-COA
HMG-CoA synthase
Reaction is reversible
Key regulatory step
HMG-CoA reductase
Catalyze NADPH-dependent, 4 electron reduction of HMG-CoA to mevalonate, double reduction of thio-ester turns into a primary alcohol and thiol
HMG-CoA + 2NADPH + 2H+ > Mevalonate + 2NADP+ + CoA-SH
This is the committing the pathway to cholesterol and isoprenoid synthesis
Committed step and primary regulatory enzyme of cholesterol biosynthesis
HMG-CoA reductase is found in the liver, in the smooth endoplasmic reticulum as a membrane protein
Statins: reduce cholesterol by blocking HMG-CoA reductase
Stage 2: Mevalonate activation and formation of activated isoprenes (IPP and DMAPP)
Mevalonate is sequentially phosphorylated three times, to create a highly activated intermediate
First 2 carboxylation occurs at C5, third one is at C3
Mevalonate (mevalonate 5-phosphotransferase) + ATP > 5-phosphomevalonate
5-phosphomevalonate (phosphomevalonate kinase) + ATP > 5-pyrophosphomevalonate
5-pyrophosphomevalonate (pyrophospho-mevalonate decarboxylase) + ATP > 3-phospho-5-pyrophosphomevalonate
The third phosphorylation at C3 primes the molecule for a decarboxylation reaction, eliminates phosphate and carboxyl group to form a double bond creating Isopentenyl pyrophosphate (IPP), first activated isoprene
IPP undergo reversible isomerization to generate dimethylallyl pyrophosphate (DMAPP), second activated isoprene
Double changes from C2=C3 to C3=C4
IPP and DMAPP serve as the fundamental five-carbon building blocks for downstream isoprenoid and sterol synthesis
IPP is the universal five-carbon building block feeding the entire isoprenoid family
Includes rubber, quinones, carotenoids, retinoids, fat-soluble vitamins and all sterol
Central launching point for vast structural and functional diversity in biology
Multiple isoprene units polymerize to squalene which is completely hydrophobic
Cyclization's make multi-ring steroid nucleus, 4 fused rings , 3 6c 1 5c rings
Used to create cholesterol, steroids, bile salts
Liver
Creates bile acid for emulsifying lipids in digestive tract
Taurocholate
Skin
Produces vitamin D for calcium signaling and gene regulation
The steroid nucleus in the presence of UV light creates cholecalciferol, Vitamin D3
Adrenal cortex
Creates steroid hormones
Glucocorticoids like cortisol
Anti-inflammation signaling
Gonads
Creates steroid hormones
Sex hormones like androgens, estrogen and testosterone
Know HMG-CoA reductase is the committed and primary regulatory step in isoprene/cholesterol biosynthesis
HMG-CoA reductase
Catalyze NADPH-dependent, 4 electron reduction of HMG-CoA to mevalonate, double reduction of thio-ester turns into a primary alcohol and thiol
HMG-CoA + 2NADPH + 2H+ > Mevalonate + 2NADP+ + CoA-SH
This is the committing the pathway to cholesterol and isoprenoid synthesis
Committed step and primary regulatory enzyme of cholesterol biosynthesis
HMG-CoA reductase is found in the liver, in the smooth endoplasmic reticulum as a membrane protein
Statins: reduce cholesterol by blocking HMG-CoA reductase